PHI with Generalized atopic dermatitis
How does this condition affect your private health insurance?
Generalized neurodermatitis, also known as atopic dermatitis, is a chronic, inflammatory skin condition characterized by intensely itchy, red, dry, and scaly patches that can affect large areas of the body. It often manifests in early childhood, though it can persist or develop in adulthood. The skin barrier is compromised, making it more susceptible to irritants and allergens. This leads to a cycle of itching and scratching, which further exacerbates the condition. Triggers include environmental factors, allergens, stress, and certain foods. While not contagious, its widespread nature can significantly impair quality of life, leading to sleep disturbances, psychological distress, and secondary infections. Management involves emollients, topical corticosteroids, and lifestyle adjustments.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 40%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
A flare-up can last from several days to several weeks, depending on severity and treatment.
Duration of Illness (Lifetime)
It is a chronic disease, often lifelong, with periods of remission and exacerbation. Some children outgrow it, but it can recur or persist into adulthood.
Cost of Treatment (Initial)
Varies widely; initial flare-up management can range from €50-€500 for topical creams, antihistamines, and specialist consultation. Severe cases requiring systemic therapy or hospitalization can be much higher.
Cost of Treatment (Lifetime)
Significant, potentially €500-€5000+ per year for continuous management, including emollients, topical medications, specialist visits, and potentially systemic treatments or biologics for severe, persistent cases.
Mortality Rate
Extremely low directly from the disease itself. Severe secondary infections, if untreated, could rarely lead to complications, but generally considered non-fatal.
Risk of Secondary Damages
High (30-60%) for secondary bacterial/viral/fungal infections (e.g., impetigo, eczema herpeticum), significant psychological impact (anxiety, depression, social stigma, sleep disturbance), and potential scarring from chronic scratching in severe cases.
Probability of Full Recovery
Variable. Around 50-70% of children experience significant improvement or remission by adolescence/adulthood, but a complete, permanent recovery without any further recurrences is less common, perhaps 20-30%. The condition often waxes and wanes.
Underlying Disease Risk
High (50-70%) due to the "atopic march." Common comorbidities include allergic rhinitis (hay fever), asthma, and food allergies.